Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.64
-0.07 (-0.20%)
Aug 31, 2026, 4:00 PM EDT - Market closed

Roivant Sciences Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
7.538.2629.0532.7131.5355.29
Revenue Growth
-67.58%-71.57%-11.19%3.75%-42.97%132.34%
Gross Profit
-723.89-673.94-516.47-398.9-425.57-413.82
Operating Income
-1,363-1,280-1,087-779.43-809.01-838.85
Net Income
-266.25-299.77-171.984,349-1,009-845.26
Earnings Per Share
-0.49-0.54-0.245.23-1.42-1.26
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
3,8424,2924,8876,4951,6772,060
Total Debt
107.15107.44100.1753.99481.4283.89
Net Cash (Debt)
3,7354,1844,7876,4411,1951,777
Net Cash Growth
-15.18%-12.58%-25.68%438.81%-32.71%-1.85%
Net Cash Per Share
5.316.036.607.751.682.65

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-816.47-750.35-839.45-765.27-843.39-677.73
Capital Expenditures
-4.59-8.21-4.6-1.38-12.69-17.44
Free Cash Flow
-821.06-758.56-844.05-766.65-856.08-695.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
------
Operating Margin
-18102.46%-15495.19%-3740.34%-2382.63%-2565.86%-1517.29%
Pretax Margin
-3848.65%-3203.12%-2346.02%13963.43%-2806.82%-1670.85%
Profit Margin
-3534.96%-3629.19%-591.96%13294.18%-3200.22%-1528.89%
FCF Margin
-10901.00%-9183.51%-2905.21%-2343.56%-2715.14%-1257.40%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
---1.95--
PS Ratio
3322.002400.11247.81259.64177.5261.84